Page 2 - Markets News

Regulatory architecture 2.0: Securities Markets Code marks a decisive shift

Part two of a three-part series on the Securities Markets Code focuses on regulatory reform as it moves from discretion to institutional design

Equity MF flows snap 3-month decline, surge 21% to ₹29,911 cr in November

Redemptions ease and SIP strength lifts industry AUM past Rs 80 trillion

GVFL leads $12 million round in renewable-energy firm Soleos Solar Energy

Funding to support expansion into storage, group-captive projects as Soleos pushes toward round-the-clock clean-power solutions

Adani Enterprises rights issue oversubscribed; to raise about ₹24,930 crore

Adani Enterprises' rights issue drew bids for nearly 150 million shares, around 8 per cent above the 138.5 million on offer, with most additional demand coming from public shareholders

Vidya Wires makes flat D-street debut at ₹52; misses GMP estimates

Ahead of debut, Vidya Wires shares were quoting at ₹55.5 in the grey market, reflecting a premium of ₹3.5 or 6.7 per cent over the issue price

Ajmera Realty shares gain 4% as new project sees 81% sell-out in 24 hours

Ajmera Realty shares rose 4 per cent after it launched a premium and mid-segment residential project and recorded an 81 per cent sell-out within hours

Purchase of digital gold contracts via UPI contracts 47% in November

The value of digital gold investments fell sharply in November after Sebi's caution, though transaction volumes rose slightly, signaling small-ticket buying continues

Sebi launches PaRRVA to verify past returns, curb misleading claims

Sebi has launched PaRRVA, a pilot mechanism by Care Ratings and NSE to verify past returns claimed by registered intermediaries, aiming to curb misleading finfluencer claims

Fino PB shares tank 12% despite RBI approval FOR transition into SFB

Profit-taking and a broader selloff drive the record fall, even as the bank gets 18 months to transition into a small finance bank with a cautious lending plan

Corona Remedies bets on female hormone complex generics ahead of IPO

Corona Remedies is pushing into female hormone complex generics to expand beyond India, as its Rs 655.3-crore OFS IPO opens December 8, with a new hormone plant and a stake in La Chandra Pharma Labs

Street Signs: Flexicaps lead MF space; IPO street set to buzz again

Flexible equity schemes top assets and inflows as investors turn cautious in a patchy market

Non-par products gain ground in listed life insurers' product mix in H1FY26

Volatile equity markets and lower deposit rates boosted demand for non-par guaranteed-return products in H1FY26, lifting their share across most listed life insurers except HDFC Life

On the upswing: Equity benchmarks gain for third consecutive month

Rotation out of AI stocks, strong Q2 earnings and FPI buying helped markets hit 14-month highs despite valuation worries

MFs' equity purchases scale a new high in 2025 amid strong inflows

Domestic funds have bought Rs 4.6 trillion worth of equities so far, surpassing 2024 highs

Stocks, mutual funds gaining fast as savers shift allegiance from banks

Share of household savings in these instruments ­has doubled over the past year

Non-Nifty 50 firms' profit engine fires up, eclipses index giants in Q2

Mid and small-cap companies delivered their fastest earnings growth in seven quarters, lifting their share of India Inc's profits even as Nifty 50 firms saw a slowdown

Smallcap funds pare core exposure as market valuation worries remain

Average small-cap allocation in top schemes has slipped to 74.4 per cent from 76.4 per cent a year ago, as elevated valuations and AMFI-led reclassification prompt fund managers to rebalance

Infosys' ₹18,000 cr buyback gets 8.3x bids; 826 mn shares tendered

Infosys' Rs 18,000-crore buyback drew bids for 826 million shares against 100 million on offer, with experts saying participation was driven by investors in lower tax brackets

Q2 scorecard: Nifty 50 companies' profit growth at 12-quarter low

Their sales uptick least in 17 quarters

Sudeep Pharma IPO subscribed 5.09 times on Day 2; NII bids hit 12x

The initial public offer of Sudeep Pharma Ltd received 5.09 times subscription on the second day of bidding on Monday. The IPO received bids for 5,37,83,650 shares against 1,05,64,926 shares on offer, according to NSE data. The category for non-institutional investors fetched 12 times subscription, while the quota for Retail Individual Investors (RIIs) got subscribed 4.96 times. The Qualified Institutional Buyers (QIBs) portion received 13 per cent subscription. Sudeep Pharma on Thursday said it has mobilised Rs 268.5 crore from anchor investors. The Rs 895 crore initial public offering (IPO) will conclude on Tuesday. The price band has been fixed at Rs 563-593 per equity share. The IPO has a fresh issue of equity shares worth Rs 95 crore and an offer-for-sale of nearly 1.35 crore equity shares, aggregating to Rs 800 crore, by the promoters. Proceeds from the fresh issue to the tune of Rs 75.81 crore will be used for capital expenditure towards the procurement of machinery for it